AGT and myocardial infarction: In the present study, we demonstrated, for the first time, that a peptide vaccine targeting Ang II (Ang II-KLH conjugate) attenuated the cardiac remodeling that leads to heart failure, improving cardiac function and suppressing adverse pathological changes in a rat model of MI.